Get started
Author

Toru Kiguchi

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
2020 · Elsa Bernard, Yasuhito Nannya, et al. · Nature Medicine · 682
PDF
Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients
2014 · R Kihara, Y Nagata, et al. · Leukemia · 254
Germ line DDX41 mutations define a unique subtype of myeloid neoplasms
2022 · Hideki Makishima, Ryunosuke Saiki, et al. · Blood · 169
Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11
2020 · Yuichi Ishikawa, Naomi Kawashima, et al. · Blood Advances · 137
Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study
2017 · The Japan Adult Leukemia Study Group, Naoto Takahashi, et al. · International Journal of Hematology · 99
Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial
2021 · Kazunori Murai, Hiroshi Ureshino, et al. · The Lancet Haematology · 68
PDF
Induction of TNF-?, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells
2003 · Masami Niiya, Kenji Niiya, et al. · Cancer Chemotherapy and Pharmacology · 56
Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol
2016 · Kazuo Tamura, Yasukazu Kawai, et al. · International Journal of Clinical Oncology · 54
Speciation of arsenic trioxide penetrates into cerebrospinal fluid in patients with acute promyelocytic leukemia
2009 · Toru Kiguchi, Yuta Yoshino, et al. · Leukemia Research · 53
Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis
2002 · Y. Emori, M. Sakugawa, et al. · Blood Coagulation & Fibrinolysis · 47
Romidepsin in Japanese patients with relapsed or refractory peripheral T-cell lymphoma: a phase I/II and pharmacokinetics study
2017 · Dai Maruyama, Kensei Tobinai, et al. · International Journal of Hematology · 38
Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms
2023 · Yasuhito Nannya, Magnus Tobiasson, et al. · Blood Advances · 34
PDF
Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents
2016 · Takayuki Katsuyama, Ken-Ei Sada, et al. · Modern Rheumatology · 32
Simultaneous induction of matrix metalloproteinase‐9 and interleukin 8 by all‐trans retinoic acid in human PL‐21 and NB4 myeloid leukaemia cells
2002 · Misako Shibakura, Kenji Niiya, et al. · British Journal of Haematology · 29
Induction of IL‐8 and monoclyte chemoattractant protein‐1 by doxorubicin in human small cell lung carcinoma cells
2002 · Misako Shibakura, Kenji Niiya, et al. · International Journal of Cancer · 25
PDF
Transfusion-transmitted hepatitis E in a patient with myelodysplastic syndromes.
2014 · Yukihiko Kimura, Akihiko Gotoh, et al. · Europe PMC (PubMed Central) · 24
TP53 State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes
2019 · Elsa Bernard, Yasuhito Nannya, et al. · Blood · 23
The Prophylactic Effect of Itraconazole Capsules and Fluconazole Capsules for Systemic Fungal Infections in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes: A Japanese Multicenter Randomized, Controlled Study
2007 · Yoshikazu Ito, Kazuma Ohyashiki, et al. · International Journal of Hematology · 21
Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, phase 1/2, safety and efficacy study
2020 · Kazutaka Sunami, Kenshi Suzuki, et al. · Cancer Science · 20
PDF
Induction of urokinase-type plasminogen activator by the anthracycline antibiotic in human RC-K8 lymphoma and H69 lung-carcinoma cells
2001 · Toru Kiguchi, Kenji Niiya, et al. · International Journal of Cancer · 17
Promising Outcome of Imatinib-Combined Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the Japan Adult Leukemia Study Group (JALSG) Ph+ALL202 Regimen.
2009 · Yoshihiro Hatta, Shuichi Mizuta, et al. · Blood · 14
Compliance with taking imatinib mesylate in patients with chronic myeloid leukemia in the chronic phase
2008 · Toru Kiguchi, Tetsuzo Tauchi, et al. · Leukemia Research · 14
A case report of TAFRO syndrome successfully treated by immunosuppressive therapies with plasma exchange
2018 · Yusuke Meguri, Noboru Asada, et al. · Annals of Hematology · 12
PDF
Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study
2018 · Kosei Matsue, Kyoya Kumagai, et al. · International Journal of Hematology · 12
Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia
2022 · Naohiro Sekiguchi, Senji Kasahara, et al. · International Journal of Hematology · 11
PDF
Works count: 109
Citation count: 2,174
H-index: 19
I10-index: 29
Year
Topic
Type